tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PolyNovo Requests Trading Halt Amid Speculation on U.S. Reimbursement Changes

Story Highlights
PolyNovo Requests Trading Halt Amid Speculation on U.S. Reimbursement Changes

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Polynovo ( (AU:PNV) ) has shared an announcement.

PolyNovo Limited has requested a trading halt on its securities pending the release of an announcement. This move is in response to press speculation about a potential positive change in U.S. reimbursement for outpatient wound care, which could significantly impact the company’s operations and market positioning.

The most recent analyst rating on (AU:PNV) stock is a Hold with a A$1.30 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.

More about Polynovo

PolyNovo Limited operates in the medical technology industry, focusing on developing and commercializing innovative wound care solutions. The company is known for its advanced products aimed at improving patient outcomes and changing lives, with a particular market focus on outpatient wound care.

YTD Price Performance: -35.54%

Average Trading Volume: 2,428,287

Technical Sentiment Signal: Sell

Current Market Cap: A$908.5M

For a thorough assessment of PNV stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1